UNREAL 20:1 High CBD Strains – Medical Marijuana Seeds
Very high CBD strains from seed. The Medical Marijuana Genetics’ Candida and Nightingale strains have tested up to 20:1 CBD:THC. Look at these strains below.
High CBD Strains
What is CBD? Cannabidiol(CBD) is a cannabinoid that is the active ingredient used for most medical marijuana treatments. Not to be confused with another cannonaded THC, CBD is claimed to be a pain-relieving, relaxing and sedative component of cannabis, without the psychoactive effects.
Who’s Breeding the Seeds? The cannabis seed breeders at Medical Marijuana Genetics have been selectively breeding high CBD strains. All starting from their flagship Candida strain, which has been tested 20.65% CBD to 0.7% THC.
Overview: Claiming to be the highest CBD and lowest THC content of any strain currently available on the seed market, Candida (CD-1) is a test destroyer 20.65% CBD : 0.7% THC strain. Apparently named after the founder of Medical Marijuana Genetics’ late mother and translates in Latin to ‘bright light’.
The tests show CBD levels of 20.6% to 10.9% CBD content. The THC levels rise with higher CBD levels, however they never seem to break past a low 1% THC content. Compared to other popular high CBD strains, Candida’s CBD and THC balance holds more consistency in selections.
Grow: Candida can be grown both indoors and outdoors. The fragrant terpenes can be brought out strong with a well prepped soil mix . Yields: 400 gr/m2, flowering time is about 9 weeks.
This hybrid cannabis strain’s genetics come from ACDC x Harlequin. Cracking Candida feminized seeds will produce two varying phenotypes; a sativa and an indica. The sativa pheno has more distance between internodes and a larger height, which can be a challenge for some growers. The indica pheno pumps out higher yields on an easy compact plant.
The sativa pheno has been tested with containing the higher amount of CBD, however not yielding as well. The indica pheno is the prized high yield producer and top best quality buds.
Buy Candida High CBD Seeds🌱
Overview: What do you get when you cross a Blue Dream, Girl Scout Cookies and Candida? You get a Hiydrow plant. This sativa dominant strain produces a high 300-500 gr/m2 yield.
Hiydrow is a high CBD ratio strain that has a slight psychoactive effect. There is a small amount of THC and a high amount of CBD.
Grow: Hiydrow’s flowering time is 7-8 weeks and can be grown outdoors, indoors or in a greenhouse. The plant develops large green calyxes on large colas. The plant displays bright red hairs during the end of flowering. High density buds with a high yield.
Hiydrow (HY-1) is a hybrid 2:1 CBD to THC strain. During tests, Hiydrow’s CBD levels ranged from 16.5% – 11.1% and the THC count ranged from 8.4%. to 6.3%. The higher CBD plants were also found to posses higher THC content.
Buy Hiydrow High CBD Seeds🌱
Green Doctor (GD-1)
Overview: If you’re a sativa haze lover, Green Doctor is the high CBD strain you need to try. Green Doctor is a high THC version of a CBD strain that leans towards its haze genetics.
Green Doctor has a high CBD level: 16.9% – 10.2% combined a moderate THC count: 12% to 3.7%. Perfect for users who want both CBD and THC. Green Doctor yields: 300-500 gr/m2.
Grow: Green Doctor is sativa dominant, and finishes its flowering process in about 10 weeks. Indoors, outdoor or greenhouse environments all work well with this mold resistant strain. This sativa dominant strain will need more room than other high CBD strains, 10 weeks of flowering is 10 weeks of growth.
The buds are spear-like and solid, with an aroma of lemony pine cleaner. The energetic sativa psychoactive effects bring a not-the-usual option to quality high CBD strains in cannabis seed banks.
Buy Green Doctor High CBD Seeds🌱
Overview: Txaki is a CBD strain with a moderate amount of psychoactive THC.
The tests of Txaki ranged from 17.5% to- 8.9% CBD and 11.4% to 4.5% THC. Txaki is ideal for the user who want’s a cerebral THC effect along with a therapeutic high CBD content.
Grow: A rare Mexican cut strain ‘Tijuana’ adds some spice into this high CBD cannabis plant. The tall growing Txaki plant is mostly sativa and does well outdoors, as well as in a greenhouse or indoor environment.
Txaki stretches and grows large during flowering, and is ready in a worthwhile 10 – 11 weeks. Indoor growers may have difficulty if they are growing Txaki in a small area. Outdoor growers should provide adequate direct sunlight and a complete nutrient regime. Yields 300-500 gr/m2.
Buy Txaki High CBD Seeds🌱
Overview: Another very high CBD strain, Nightingale has tested a whopping 20.3% to 10.3% CBD content in studies. THC levels vary significantly from plant to plant.
This Nightingale strain is named after Florence Nightingale, a trailblazing figure in nursing. Nightingale has very high CBD levels in an easy to grow Indica dominant plant full of colors.
Grow: Nightingale flowers in 8 – 9 weeks. The flowering plants produce a strong berry flavor and aroma. For indoor and outdoor growing. Ideally, providing a low humidity climate and plenty of airflow to the plant in flowering helps to ensure against mold problems. Yields are 300-500 gr/m2.
It appears the indica dominant seedlings the one responsible for the 20:1 high CBD phenotypes, whereas the sativa dominant plants are more 1:1.
Buy Nightingale High CBD Seeds🌱
What is a high CBD strain?
A high CBD strain is a variety of the cannabis plant that contains high levels of the cannabinoid CBD. CBD is the prime choice of medical marijuana users looking for a relaxing, sedative effect.
- CBD stands for cannabidiol, an active chemical(cannabinoid) in the cannabis plant.
- Present in high quantities, CBD ranks in as the second most voluminous cannabinoid in cannabis, with the first being psychoactive THC.
- Revered for its usage in medical marijuana, CBD’s soothing qualities do not induce any noticeably ‘high’ effects. Rather CBD provides relief and relaxation.
- High CBD strains are defined as having over a 3-4% CBD profile.
Cannabis seed breeders try to hit or exceed a 1:1 CBD to THC ratio for their strains. The less THC present, the less psychoactive effects there are going to be. The option to choose your effect opens the cannabis door up for users who do not want to feel high, or do.
Medical Marijuana Genetics Seeds
Medical Marijuana Genetics was founded in 2014. The founder’s mother was fighting late stage pancreatic cancer. After the mother’s first dose of cannabis oil, she was able to tend her garden, get up and move around fairly pain-free in the time leading up to her death.
Cannabis oil had given her a therapeutic effect that was easily seen by those close to her. This evoked inspiration to explore the science of medical marijuana. Medical Marijuana Genetics started out as an informative medical cannabis website that now has evolved into a full scale plant and seed breeding company.
For the majority of cannabis strains available on the market, breeders found out quick that this illusive cannabinoid CBD is not always easy to produce in quality regularly. A few breeders were up for that challenge. Medical Marijuana Genetics was formed by award winning growers and breeders from the Basque region of Spain. Focusing their efforts mainly on developing CBD dominant marijuana seeds and strains.
Using top quality hybrids and established cannabis strains, Medical Marijuana Genetics successfully created their flagship Candida (CD-1) strain. First lab tests results blew minds, with Candida testing up to a monstrous 20.65% CBD – 0.7% THC content. Claimed to be the highest known consistent ratios in a high CBD seed strain yet. These excellent results fueled the fire for the creation of a whole line of high CBD strains fit for each and every grower.
These seeds just dropped so get them while they’re hot! Medical Marijuana Genetics strains all contain a high amount of beneficial CBD. THC and terpene levels vary per strain.
|Candida (CD-1)||20:1||VIEW STRAIN ►|
|Hiydrow (HY-1)||2:1||VIEW STRAIN ►|
|Green Doctor (GD-1)||2:1||VIEW STRAIN ►|
|Txaki (TX-1)||2:1||VIEW STRAIN ►|
|Nightingale (NN-1)||20:1||VIEW STRAIN ►|
Very high CBD strains from seed. The Medical Marijuana Genetics' Candida and Nightingale strains have tested up to 20:1 CBD:THC.
That Purple Kush You’re Toking Might Be a Genetic Imposter
To revist this article, visit My Profile, then View saved stories.
To revist this article, visit My Profile, then View saved stories.
Cannabis strain names can get a bit … quirky (Lamb’s Bread, anyone?). But without them, patients that rely on marijuana to treat ailments like pain would be lost. If you want to treat seizures, you might want ACDC—a strain that expresses almost zero THC and very high CBD, a non-psychoactive cannabinoid—and stay away from the potentially panic-inducing Ghost OG, which verges on 25 percent THC.
Unfortunately, there isn’t an official federal database with information about cannabis strains, for obvious reasons. After all, this hasn’t been a regulated industry—you’re not allowed to call a Gala apple a Red Delicious, but no one is stopping you from calling your crop ACDC when it is in fact Ghost OG. It’s a big problem examined in a new study, posted to the preprint site BioRxiv, from the University of Northern Colorado. Researchers there bought samples of 30 separate cannabis strains, several for each, from dispensaries and compared them genetically.
Almost every strain, they found, had at least one sample that was a genetic mismatch (aka an imposter). And while strains did fall generally into one of two genetic groups, they didn’t fall neatly into the well-popularized dichotomy of indica and sativa.
The researchers looked at commonly used genetic markers called microsatellites, which have a high rate of mutation. Those mutations make it easier for scientists to identify differences between individuals. The researchers got their hands on as many as nine and as few as two samples of each strain, and compared them genetically in this way.
Cannabis strains are genetically unique because for decades, growers—particularly in Northern California’s famous Emerald Triangle, which provides perhaps three quarters of the marijuana in the US—have developed varieties of the cannabis plant by selecting for desirable traits. If you’ve got an individual plant that produces more THC, or grows faster, or produces bigger buds, you can take a cutting of that individual and grow a new plant from it. That’d make it a clone, genetically identical to its mother.
That results in unique strains that the researchers could sample genetically. “Out of the 30 strains, there were only four that were genetically consistent,” says geneticist Anna Schwabe, lead author on the paper. Something was awry. It could be that the grower sincerely believed they were growing Durban Poison, but in fact had a slightly different strain—or that somewhere in the process the product was mislabeled.
“It’s not necessarily that somebody is doing anything malicious,” Schwabe says. Growers typically identifying their strains by smell, or color of their buds. “But because there are so many strains, it starts to get really hard to correctly identify plants based on their morphological characteristics.”
Then the answer is cloning, right? Get what you know is Purple Kush and just take cuttings of your mother plant to clone it. Not so fast. Sure, you’d get the right genetics, but genes aren’t everything. Even if you know you have Purple Kush, it can express different traits depending on environmental factors like light. “When you hear these cultivators like, ‘Oh I’ve had the same mother plant for 10 years,’ well, you definitely weren’t producing the same clones all the time,” says Jeff Raber, CEO of the Werc Shop, a lab that tests cannabis, “because it’s a different mother the second time you go back because you stressed the daylights out of her taking the first round of clones.”
Really, this variability isn’t unique to cannabis. Depending on where and how it’s grown, a particular variety of apple will vary as well. We still call a Red Delicious apple a Red Delicious, even if it isn’t as red or delicious as we expect.
So this is not a call to abolish cannabis strain naming conventions. “We need names,” says Jonathan Page, CEO of Anandia Labs, who coauthored a previous study showing genetic inconsistencies in cannabis strains. “In every other thing we consume—whether it’s wine and merlot, Red Delicious apples, or cherry tomatoes—we name things.”
This new study also found problems with the famous indica-sativa cannabis divide—indica strains are supposedly more for sleepy times while sativa is supposedly more uplifting. You’d expect, then, for strains to map neatly to one of the two groups. While the study did find two genetic groups, they didn’t correspond well to known indica or sativa strains. For example, the researchers found that Grape Ape, an indica strain, didn’t assign particularly well to either of these novel genetic groups. “There’s not very much evidence to support the widespread use of indica, sativa, and hybrid in classifying cannabis,” says Page. “However, they did find in this paper a suggestion of certain genotypes to which strains can be more closely related.”
“The other issue to keep in mind is that these things have been crossed by humans for a long time,” says plant evolutionary biologist Mitchell McGlaughlin, coauthor on the new paper. One theory holds that sativa and indica are separate species that were once geographically isolated. “That very well could be true, but then when you have hundreds if not thousands of years of humans then modifying that plant and making crosses—and in the wild this would be a wind-pollinated plant with pollen traveling reasonable distances—you then end up with issues where that historic signal has been lost.”
There are some caveats to consider with this new study, though. Again, the cannabis sample sizes here were small—as few as two for some strains. Because it’s preprint, it hasn’t been peer reviewed, the gold standard in scientific publishing. And microsatellites aren’t the only way to go about genetically testing cannabis—Page’s study, for instance, looked more broadly at the genomes, while microsatellites are a more targeted approach on those mutation-prone regions.
“They might be right, but far too many people in this field are using shady sub-par genomic methods to make claims that they are the arbiter of cannabis truth without subjecting their methods to peer review before doing so,” says Kevin McKernan, chief science officer of cannabis lab Medicinal Genomics.
These are very early days for cannabis research. But this study also shows how research like this is finally getting easier. Historically, the University of Mississippi has been the sole provider of research cannabis, and the quality ain’t super. But because marijuana is legal in Colorado, these researchers could procure their own samples of unique strains. Better access means better research—and a better understanding of the genetics that code for what is still one of the most mysterious plants on Earth.
ACDC and Lamb's Bread and Ghost OG, oh my: Researchers compare the genetics of cannabis strains and find … irregularities.